Matches in SemOpenAlex for { <https://semopenalex.org/work/W1734684804> ?p ?o ?g. }
- W1734684804 endingPage "79" @default.
- W1734684804 startingPage "465" @default.
- W1734684804 abstract "To make recommendations to physicians providing prenatal care on (1) whether prenatal screening for and diagnosis of Down syndrome (DS) is advisable and (2) alternative screening and diagnosis manoeuvres.Triple-marker screening of maternal serum levels of alpha-fetoprotein, human chorionic gonadotropin and unconjugated estriol; fetal ultrasonographic examination; amniocentesis; and chorionic villus sampling (CVS).Accuracy of detection of DS in fetuses, and risks to the mother, including psychologic distress, and to the fetus from the screening and diagnostic interventions.A MEDLINE search for relevant articles published from Jan. 1, 1966, to Mar. 31, 1994, with the use of MeSH terms Down syndrome, prenatal diagnosis, screening, prevention, amniocentesis, chorionic villus sampling, ultrasonography, anxiety, depression and psychological stress and a manual search of bibliographies, recent issues of key journals and Current Contents.The evidence-based methods and values of the Canadian Task Force on the Periodic Health Examination were used. A high value was placed on providing pregnant women with the opportunity to determine whether they are carrying a fetus with DS and to make choices concerning the termination of the pregnancy. The economic issues involved are complex and were not considered.Triple-marker screening identifies an estimated 58% of fetuses with DS, but it has an estimated rate of true-positive results of 0.1% and of false-positive results of 3.7% (given a risk cut-off of one chance in 190 of DS). These rates vary with maternal age and the risk cut-off chosen. Women with a known risk of having a fetus with DS (e.g., those who have had a previous child with DS) may benefit from a reduction in anxiety after confirmation that their fetus does not have DS. Screening allows women at low risk of having a child with DS to detect fetuses with the syndrome, but may cause psychologic distress if there is a false-positive screening test result. Up to 20% of women with positive results of screening tests may decline to undergo a subsequent amniocentesis. Amniocentesis and CVS are very accurate in diagnosing DS in fetuses and have a very low rate of serious complications for the mother. Amniocentesis is associated with a 1.7% rate of fetal loss when it is performed after 16 weeks' gestation, whereas the rate among controls is 0.7% (for a difference of 1%, 95% confidence interval 0.3% to 1.5%). CVS entails a greater risk of fetal loss than amniocentesis (odds ratio 1.32, 95% confidence interval 1.11 to 1.57). There is little evidence from controlled trials of significant associations between amniocentesis or CVS and neonatal morbidity or malformations; however, samples have been too small to show differences in rare outcomes. Results from some case-control studies suggest that CVS increases the risk of transverse limb deficiency. Costs were not considered because they are beyond the scope of this review.There is fair evidence to offer triple-marker screening through a comprehensive program to pregnant women under 35 years of age (grade B recommendation). Women given detailed information about serum-marker screening show more satisfaction with the screening than those not given this information. There is fair evidence to offer amniocentesis or CVS to pregnant women 35 years of age and older and to women with a history of a fetus with DS or of a chromosome 21 anomaly (grade B recommendation). Information on the limitations and advantages of each procedure should be offered. Triple-marker screening may be offered as an alternative to CVS or amniocentesis to pregnant women over 35.Recommendations concerning prenatal diagnosis are similar to those of the US Preventive Services Task Force, the Society of Obstetricians and Gynaecologists of Canada, the Canadian College of Medical Geneticists and the Cochrane Pregnancy and Childbirth Group. No previous specific recommendations concerning triple-maker screening exist.These guidelines were developed and endorsed by the Canadian Task Force on the Periodic Health Examination, which is funded by Health Canada and the National Health Research and Development Program." @default.
- W1734684804 created "2016-06-24" @default.
- W1734684804 creator A5032533894 @default.
- W1734684804 date "1996-02-15" @default.
- W1734684804 modified "2023-09-29" @default.
- W1734684804 title "Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination." @default.
- W1734684804 cites W109614683 @default.
- W1734684804 cites W14033087 @default.
- W1734684804 cites W1496325591 @default.
- W1734684804 cites W1552905578 @default.
- W1734684804 cites W1561780468 @default.
- W1734684804 cites W1581121453 @default.
- W1734684804 cites W171613887 @default.
- W1734684804 cites W1793096830 @default.
- W1734684804 cites W1826800499 @default.
- W1734684804 cites W1846712277 @default.
- W1734684804 cites W1873867655 @default.
- W1734684804 cites W1901605689 @default.
- W1734684804 cites W1961546380 @default.
- W1734684804 cites W1963804641 @default.
- W1734684804 cites W1966383222 @default.
- W1734684804 cites W1967524590 @default.
- W1734684804 cites W1967853679 @default.
- W1734684804 cites W1969158204 @default.
- W1734684804 cites W1970082445 @default.
- W1734684804 cites W1974745989 @default.
- W1734684804 cites W1975262090 @default.
- W1734684804 cites W1975480100 @default.
- W1734684804 cites W1977168855 @default.
- W1734684804 cites W1982627349 @default.
- W1734684804 cites W1983050860 @default.
- W1734684804 cites W1985540014 @default.
- W1734684804 cites W1986323647 @default.
- W1734684804 cites W1986621139 @default.
- W1734684804 cites W1987059095 @default.
- W1734684804 cites W1987469551 @default.
- W1734684804 cites W1989169267 @default.
- W1734684804 cites W1989676111 @default.
- W1734684804 cites W1990528432 @default.
- W1734684804 cites W1992009168 @default.
- W1734684804 cites W1992892846 @default.
- W1734684804 cites W1993924149 @default.
- W1734684804 cites W1994933000 @default.
- W1734684804 cites W1995289162 @default.
- W1734684804 cites W1998298027 @default.
- W1734684804 cites W1998861400 @default.
- W1734684804 cites W2001746285 @default.
- W1734684804 cites W200398452 @default.
- W1734684804 cites W2010804880 @default.
- W1734684804 cites W2011245539 @default.
- W1734684804 cites W2017524963 @default.
- W1734684804 cites W2018741759 @default.
- W1734684804 cites W2019818504 @default.
- W1734684804 cites W2021165289 @default.
- W1734684804 cites W2021737450 @default.
- W1734684804 cites W2021943331 @default.
- W1734684804 cites W2026967037 @default.
- W1734684804 cites W2027877596 @default.
- W1734684804 cites W2028925263 @default.
- W1734684804 cites W2030645242 @default.
- W1734684804 cites W2032394527 @default.
- W1734684804 cites W2034462880 @default.
- W1734684804 cites W2035753509 @default.
- W1734684804 cites W2037500578 @default.
- W1734684804 cites W2038452732 @default.
- W1734684804 cites W2038759796 @default.
- W1734684804 cites W2040022502 @default.
- W1734684804 cites W2041156035 @default.
- W1734684804 cites W2041956734 @default.
- W1734684804 cites W2043934109 @default.
- W1734684804 cites W2045530837 @default.
- W1734684804 cites W2046484004 @default.
- W1734684804 cites W2050259031 @default.
- W1734684804 cites W2052368916 @default.
- W1734684804 cites W2052665680 @default.
- W1734684804 cites W2054013259 @default.
- W1734684804 cites W2058787935 @default.
- W1734684804 cites W2060334092 @default.
- W1734684804 cites W2062894688 @default.
- W1734684804 cites W2063728961 @default.
- W1734684804 cites W2065924237 @default.
- W1734684804 cites W2066839254 @default.
- W1734684804 cites W2067078824 @default.
- W1734684804 cites W206783874 @default.
- W1734684804 cites W2068780964 @default.
- W1734684804 cites W2069957299 @default.
- W1734684804 cites W2070573549 @default.
- W1734684804 cites W2071132428 @default.
- W1734684804 cites W2071451314 @default.
- W1734684804 cites W2083166228 @default.
- W1734684804 cites W2083614299 @default.
- W1734684804 cites W2085139647 @default.
- W1734684804 cites W2085809389 @default.
- W1734684804 cites W2085922662 @default.
- W1734684804 cites W2086658974 @default.
- W1734684804 cites W2087370533 @default.
- W1734684804 cites W2088432697 @default.
- W1734684804 cites W2089929683 @default.